RAC 5.10% $1.86 race oncology ltd

General Comments / Chat, page-7608

  1. 2,784 Posts.
    lightbulb Created with Sketch. 2463
    Too all the impatient people....

    ALL IMO

    A lot of peeps want RAC to release information yesterday!
    To release information prematurely would negatively impact the value of our asset, Zantrene.
    If you don't understand why, then you better get educated. sneaky.png
    RAC has been proving up our asset to maximise the sale price, be it outright sale, joint venture or licence.
    ...and management don't have to be too smart to ignore your insecurities and lack of patience.
    DCB appears responsive, if you have a concern please ask him.

    Then there are those on HC acting like your friend but sniff a trading opportunity and want the prove to drop.
    They continue the narrative to buy at lower values. I say good luck to them.

    RAC cannot hold onto negative news, and we are not seeing any negative announcements.

    Importantly, RAC have admitted/alluded they have information (could be multiple pieces) which cannot be published until a patent application is lodged and/or a scientific paper is produced for peer review. If this is true, then management would not be in a position to purchase shares until news was released.

    GLTAH
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.